Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29 EUR | +0.69% | 0.00% | +9.02% |
07-04 | BRITISH AMERICAN TOBACCO : JP Morgan reiterates its Neutral rating | ZD |
07-03 | BRITISH AMERICAN TOBACCO : RBC reiterates its Neutral rating | ZD |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 3.28 times its current sales, is high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.02% | 69.77B | - | ||
+8.55% | 159B | B- | ||
+32.46% | 6.77B | B- | ||
+105.47% | 2.7B | - | C+ | |
-1.41% | 1.82B | - | ||
-6.03% | 1.67B | - | D+ | |
-28.70% | 1.18B | - | B+ | |
0.00% | 641M | - | - | |
+25.61% | 583M | C+ | ||
-36.27% | 436M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- BMTA Stock
- Ratings British American Tobacco p.l.c.